Rufinamide
روفینامید
🧠 Nervous SystemAntiepileptic (triazole)
Market / country: 🇺🇸 USA
Banzel (US)
🧮 Dose calculator
Lennox-Gastaut syndrome · Regimen source: FDA Rufinamide susp. · 2.1
- • Increase by 10 mg/kg every other day up to 45 mg/kg/day (not over 3200 mg). With food. Start lower with valproate. FDA Rufinamide susp. · 2.1FDA Rufinamide susp. · 2.5
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Familial short QT syndrome. FDA Rufinamide susp. · 4
Formulations
- 40 mg/mL oral suspension — suspension 🇺🇸 USA FDA Rufinamide susp. · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Rufinamide susp. · 8.1
“Risk Summary There are no adequate data on the developmental risks associated with use of rufinamide in pregnant women.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Rufinamide susp. · 8.2
“Risk Summary There are no data on the presence of rufinamide in human milk, the effects on the breastfed infant, or the effects of the drug on milk production.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Rufinamide susp. · 8.4
“Safety and effectiveness have been established in pediatric patients 1 to 17 years of age.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Rufinamide susp. · 8.5
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Rufinamide susp. · 8.3
“Contraception Use of rufinamide may reduce the effectiveness of hormonal contraceptives containing ethinyl estradiol or norethindrone.”
🔗 Reference links
- FDA (approval record)ANDA213410
- DailyMed (FDA label)FDA Rufinamide susp.
- MedlinePlus (NIH)Rufinamide
- WHO ATC/DDDN03AF03
- Darooyab (Iran)Rufinamide
🇮🇷 Registered in Iran Darooyab · G-684/Rufinamide
Dosage forms with Iranian generic codes, per Darooyab.
- 20060 · RUFINAMIDE 200MG TAB · قرص روفینامید ۲۰۰ میلیگرم
- 20809 · RUFINAMIDE 400MG TAB · قرص روفینامید ۴۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Rufinamide susp. · 3FDA Rufinamide susp. · 2.1FDA Rufinamide susp. · 2.5FDA Rufinamide susp. · 4FDA Rufinamide susp. · SPL approval / marketing categoryFDA Rufinamide susp. · 8.1FDA Rufinamide susp. · 8.2FDA Rufinamide susp. · 8.4FDA Rufinamide susp. · 8.5FDA Rufinamide susp. · 8.3
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-684/Rufinamide
- Clinical review⚠ Unverified